Eledon Pharmaceuticals, Inc. (NVUS): Price and Financial Metrics
NVUS Price/Volume Stats
| Current price | $14.60 | 52-week high | $27.32 |
| Prev. close | $15.40 | 52-week low | $4.50 |
| Day low | $14.60 | Volume | 87,000 |
| Day high | $15.77 | Avg. volume | 0 |
| 50-day MA | $19.62 | Dividend yield | N/A |
| 200-day MA | $13.14 | Market Cap | 20.97M |
NVUS Stock Price Chart Interactive Chart >
Eledon Pharmaceuticals, Inc. (NVUS) Company Bio
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Latest NVUS News From Around the Web
Below are the latest news stories about Novus Therapeutics Inc that investors may wish to consider to help them evaluate NVUS as an investment opportunity.
Novus Therapeutics (NVUS) Investor Presentation - SlideshowThe following slide deck was published by Novus Therapeutics, Inc. in conjunction with this event.... |
NVUS Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -65.48% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 47.51% |
| 2019 | -63.75% |
Loading social stream, please wait...